A Study Evaluating the Overall Pain Relief and Safety of Intravenous (IV) CR845 in Patients Undergoing Abdominal Surgery

NCT02542384 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

451

Enrollment

INDUSTRY

Sponsor class

Conditions

Post Abdominal Surgery Pain

Interventions

DRUG: CR845 IV 1 mcg/kg
DRUG: CR845 IV 0.5 mcg/kg
DRUG: Placebo IV

Sponsor

Cara Therapeutics, Inc.